{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:01:48Z","timestamp":1793674908632,"version":"4.5.1"},"reference-count":118,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.ecl.2014.06.001","type":"journal-article","created":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T05:39:25Z","timestamp":1409031565000},"page":"807-828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Endocrinopathies in Children Infected with Human Immunodeficiency Virus"],"prefix":"10.1016","volume":"43","author":[{"given":"Lindsey A.","family":"Loomba-Albrecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Bregman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline J.","family":"Chantry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2014.06.001_bib1","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). Global report. UNAIDS report on the global AIDS epidemic. 2013. Available at: http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/epidemiology\/2013\/gr2013\/UNAIDS_Global_Report_2013_en.pdf. Accessed March 20, 2014."},{"issue":"2","key":"10.1016\/j.ecl.2014.06.001_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00000441-200102000-00005","article-title":"Adrenal insufficiency in HIV infection: a review and recommendations","volume":"321","author":"Eledrisi","year":"2001","journal-title":"Am J Med Sci"},{"issue":"19","key":"10.1016\/j.ecl.2014.06.001_bib3","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM199211053271906","article-title":"HIV disease and the endocrine system","volume":"327","author":"Grinspoon","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ecl.2014.06.001_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11154-013-9244-x","article-title":"Human immune deficiency virus (HIV) infection and the hypothalamic pituitary adrenal axis","volume":"14","author":"George","year":"2013","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"10.1016\/j.ecl.2014.06.001_bib5","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0025-7125(05)70498-3","article-title":"Endocrinologic complications of HIV infection","volume":"80","author":"Danoff","year":"1996","journal-title":"Med Clin North Am"},{"issue":"5","key":"10.1016\/j.ecl.2014.06.001_bib6","first-page":"518","article-title":"Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome","volume":"17","author":"Sellmeyer","year":"1996","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.ecl.2014.06.001_bib7","first-page":"247","article-title":"Addison-disease - an unusual clinical manifestation of CMV-end organ disease in pediatric AIDS","volume":"5","author":"Seel","year":"2000","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.ecl.2014.06.001_bib8","unstructured":"Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infections. Available at: http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/pediatricguidelines.pdf. Accessed April 2, 2014."},{"key":"10.1016\/j.ecl.2014.06.001_bib9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jpeds.2005.11.034","article-title":"Cushing syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone","volume":"148","author":"Johnson","year":"2006","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ecl.2014.06.001_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/apc.2006.0117","article-title":"Cushing syndrome and severe adrenal suppression caused by fluticasone and protease inhibitor combination in an HIV-infected adolescent","volume":"21","author":"St Germain","year":"2007","journal-title":"AIDS Patient Care STDS"},{"issue":"7","key":"10.1016\/j.ecl.2014.06.001_bib11","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1345\/aph.1K075","article-title":"Exogenous cushing syndrome with inhaled fluticasone in a child receiving lopinavir\/ritonavir","volume":"41","author":"Bhumbra","year":"2007","journal-title":"The Annals of Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.ecl.2014.06.001_bib12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1530\/JOE-12-0310","article-title":"Fluconazole inhibits human adrenocortical steroidogenesis in vitro","volume":"215","author":"van der Pas","year":"2012","journal-title":"J Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2014.06.001_bib13","first-page":"101","article-title":"Functional adrenal insufficiency among critically ill patients with human immunodeficiency virus in a resource-limited setting","volume":"7","author":"Meya","year":"2007","journal-title":"Afr Health Sci"},{"issue":"1","key":"10.1016\/j.ecl.2014.06.001_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jama.2011.915","article-title":"Association of prenatal and postnatal exposure to lopinavir-ritonavir and adrenal dysfunction among uninfected infants of HIV-infected mothers","volume":"306","author":"Simon","year":"2011","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ecl.2014.06.001_bib15","first-page":"633","article-title":"Adrenal function in HIV infected patients","volume":"121","author":"Verges","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"3","key":"10.1016\/j.ecl.2014.06.001_bib16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1210\/jcem-65-3-482","article-title":"Adrenocortical function in acquired immunodeficiency syndrome","volume":"65","author":"Membreno","year":"1987","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2014.06.001_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1590\/S1413-86702001000200002","article-title":"Low-dose adrenocorticotropin test in patients with the acquired immunodeficiency syndrome","volume":"5","author":"Wolff","year":"2001","journal-title":"Braz J Infect Dis"},{"issue":"3","key":"10.1016\/j.ecl.2014.06.001_bib18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1210\/jcem-70-3-578","article-title":"Steroid response to adrenocorticotropin stimulation in children with human immunodeficiency virus infection","volume":"70","author":"Oberfield","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2014.06.001_bib19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0022-3476(05)80685-7","article-title":"Growth and neuroendocrine dysfunction in children with acquired immunodeficiency syndrome","volume":"117","author":"Laue","year":"1990","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.ecl.2014.06.001_bib20","first-page":"330","article-title":"Endocrine function in children with human immunodeficiency virus infection","volume":"145","author":"Schwartz","year":"1991","journal-title":"Am J Dis Child"},{"issue":"12","key":"10.1016\/j.ecl.2014.06.001_bib21","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/01.inf.0000100575.64298.bc","article-title":"Growth, survival and viral load in symptomatic childhood human immunodeficiency virus infection","volume":"22","author":"Chantry","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.ecl.2014.06.001_bib22","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jpeds.2012.11.025","article-title":"Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virus","volume":"162","author":"Shiau","year":"2013","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.ecl.2014.06.001_bib23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00002030-199509050-00007","article-title":"Onset of clinical signs in children with HIV-1 perinatal infection. Italian Register for HIV Infection in Children","volume":"9","author":"Galli","year":"1995","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.ecl.2014.06.001_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1753-4887.2009.00207.x","article-title":"Patterns of postnatal growth in HIV-infected and HIV-exposed children","volume":"67","author":"Isanaka","year":"2009","journal-title":"Nutr Rev"},{"issue":"1","key":"10.1016\/j.ecl.2014.06.001_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0022-3476(96)70428-6","article-title":"Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group","volume":"128","author":"Moye","year":"1996","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.ecl.2014.06.001_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.inf.0000148879.83854.7e","article-title":"Morbidity and mortality during the first two years of life among uninfected children born to human immunodeficiency virus type 1-infected women: the women and infants transmission study","volume":"24","author":"Paul","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.ecl.2014.06.001_bib27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/QAI.0b013e3182a7adb2","article-title":"Infant growth outcomes after maternal tenofovir disoproxil fumarate use during pregnancy","volume":"64","author":"Ransom","year":"2013","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.ecl.2014.06.001_bib28","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-3476(05)83177-4","article-title":"Delayed somatic growth and pubertal development in human immunodeficiency virus-infected hemophiliac boys: Hemophilia Growth and Development Study","volume":"124","author":"Gertner","year":"1994","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.ecl.2014.06.001_bib29","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/01.inf.0000157095.75081.43","article-title":"Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy","volume":"24","author":"Nachman","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.ecl.2014.06.001_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/QAD.0b013e3283269dfb","article-title":"Morphologic and metabolic abnormalities in vertically HIV-infected children and youth","volume":"23","author":"Aldrovandi","year":"2009","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.ecl.2014.06.001_bib31","doi-asserted-by":"crossref","first-page":"E77","DOI":"10.1542\/peds.107.5.e77","article-title":"The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children","volume":"107","author":"Miller","year":"2001","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ecl.2014.06.001_bib32","doi-asserted-by":"crossref","first-page":"E72","DOI":"10.1542\/peds.108.4.e72","article-title":"Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children","volume":"108","author":"Buchacz","year":"2001","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.ecl.2014.06.001_bib33","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.1542\/peds.109.2.e25","article-title":"Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth","volume":"109","author":"Verweel","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.ecl.2014.06.001_bib34","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1515\/jpem-2011-0464","article-title":"Growth patterns in pubertal HIV-infected adolescents and their correlation with cytokines, IGF-1 IGFBP-1, and IGFBP-3","volume":"26","author":"Kessler","year":"2013","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2014.06.001_bib35","first-page":"2957","article-title":"Proteolysis of insulin-like growth factor-binding protein-3 in human immunodeficiency virus-positive children who fail to thrive","volume":"81","author":"Frost","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2014.06.001_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.inf.0000247131.76584.af","article-title":"Endocrine abnormalities and impaired growth in human immunodeficiency virus-infected children","volume":"26","author":"Chantry","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2014.06.001_bib37","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/00042560-200010001-00006","article-title":"Growth failure in children with HIV infection","volume":"25","author":"Arpadi","year":"2000","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"5","key":"10.1016\/j.ecl.2014.06.001_bib38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/088922202753519106","article-title":"Insulin-like growth factor I (IGF-I) and IGF-binding protein 3 response to growth hormone is impaired in HIV-infected children","volume":"18","author":"Rondanelli","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4","key":"10.1016\/j.ecl.2014.06.001_bib39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0022-3476(05)80685-7","article-title":"Growth and neuroendocrine dysfunction in children with acquired immunodeficiency syndrome","volume":"117","author":"Laue","year":"1990","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.ecl.2014.06.001_bib40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1542\/peds.86.2.309","article-title":"Growth hormone deficiency in an 8-year-old girl with human immunodeficiency virus infection","volume":"86","author":"Jospe","year":"1990","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ecl.2014.06.001_bib41","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jpeds.2004.04.053","article-title":"Growth hormone deficiency in HIV-infected children following successful treatment with highly active antiretroviral therapy","volume":"145","author":"Watson","year":"2004","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.ecl.2014.06.001_bib42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/QAI.0b013e31817bbe6d","article-title":"Insulin-like growth factor-1 and lean body mass in HIV-infected children","volume":"48","author":"Chantry","year":"2008","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.ecl.2014.06.001_bib43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1203\/00006450-199307000-00016","article-title":"In\u00a0vitro insulin-like growth factor-I, growth hormone, and insulin resistance occurs in symptomatic human immunodeficiency virus-1-infected children","volume":"34","author":"Geffner","year":"1993","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.ecl.2014.06.001_bib44","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00006454-200301000-00017","article-title":"Endocrinologic and immunologic factors associated with recovery of growth in children with human immunodeficiency virus type 1 infection treated with protease inhibitors","volume":"22","author":"Van Rossum","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.ecl.2014.06.001_bib45","first-page":"504","article-title":"Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy","volume":"86","author":"Rietschel","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2014.06.001_bib46","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00002030-200307040-00003","article-title":"Impaired growth hormone secretion correlates with visceral adiposity in highly active antiretroviral treated HIV-infected adolescents","volume":"17","author":"Vigano","year":"2003","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.ecl.2014.06.001_bib47","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.104.6.e73","article-title":"Evaluation of the effects of oxandrolone on malnourished HIV-positive pediatric patients","volume":"104","author":"Fox-Wheeler","year":"1999","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.ecl.2014.06.001_bib48","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/QAD.0b013e328361195b","article-title":"Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment","volume":"27","author":"Williams","year":"2013","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.ecl.2014.06.001_bib49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00126334-200305010-00009","article-title":"Delayed onset of pubertal development in children and adolescents with perinatally acquired HIV infection","volume":"33","author":"Buchacz","year":"2003","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"12","key":"10.1016\/j.ecl.2014.06.001_bib50","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/00002030-200108170-00010","article-title":"Puberty in perinatal HIV-1 infection: a multicentre longitudinal study of 212 children","volume":"15","author":"de Martino","year":"2001","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.ecl.2014.06.001_bib51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00126334-199908010-00012","article-title":"HIV-associated immune dysfunction and delayed pubertal development in a cohort of young hemophiliacs. Hemophilia Growth and Development Study","volume":"21","author":"Mahoney","year":"1999","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"10","key":"10.1016\/j.ecl.2014.06.001_bib52","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1089\/apc.2005.19.655","article-title":"A\u00a0review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras: diagnosis, pathogenesis, and management","volume":"19","author":"Crum","year":"2005","journal-title":"AIDS Patient Care STDS"},{"issue":"12","key":"10.1016\/j.ecl.2014.06.001_bib53","doi-asserted-by":"crossref","first-page":"e28512","DOI":"10.1371\/journal.pone.0028512","article-title":"Premature decline of serum total testosterone in HIV-infected men in the HAART-era","volume":"6","author":"Rochira","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ecl.2014.06.001_bib54","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.inf.0000114903.05472.e4","article-title":"Thyroid dysfunction in antiretroviral treated children","volume":"23","author":"Vigano","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.ecl.2014.06.001_bib55","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1086\/519978","article-title":"Thyroid function abnormalities in HIV-infected patients","volume":"45","author":"Hoffmann","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ecl.2014.06.001_bib56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0022-3476(96)70429-8","article-title":"Thyroid abnormalities in children infected with human immunodeficiency virus","volume":"128","author":"Hirschfeld","year":"1996","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.ecl.2014.06.001_bib57","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1089\/thy.2000.10.499","article-title":"Thyroid function in children with perinatal human immunodeficiency virus type 1 infection","volume":"10","author":"Chiarelli","year":"2000","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.ecl.2014.06.001_bib58","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/JPEM.2004.17.1.33","article-title":"Endocrine function in Thai children infected with human immunodeficiency virus","volume":"17","author":"Panamonta","year":"2004","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2014.06.001_bib59","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1515\/JPEM.1998.11.6.745","article-title":"Occurrence of anti-thyroid autoantibodies in children vertically infected with HIV-1","volume":"11","author":"Fundaro","year":"1998","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2014.06.001_bib60","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1089\/thy.2012.0055","article-title":"Hashimoto's thyroiditis presenting as acute painful thyroiditis and as a manifestation of an immune reconstitution inflammatory syndrome in a human immunodeficiency virus-seropositive patient","volume":"22","author":"Visser","year":"2012","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.ecl.2014.06.001_bib61","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11154-013-9248-6","article-title":"HIV and thyroid dysfunction","volume":"14","author":"Parsa","year":"2013","journal-title":"Rev Endocr Metab Disord"},{"issue":"5","key":"10.1016\/j.ecl.2014.06.001_bib62","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/QAD.0b013e32832407e2","article-title":"Graves' disease following successful HAART of a perinatally HIV-infected 11-year-old","volume":"23","author":"Perez","year":"2009","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.ecl.2014.06.001_bib63","first-page":"424","article-title":"Thyroid dysfunction in HIV-infected children: is L-thyroxine therapy beneficial?","volume":"7","author":"Rana","year":"1996","journal-title":"Pediatr AIDS HIV Infect"},{"issue":"8","key":"10.1016\/j.ecl.2014.06.001_bib64","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/QAD.0b013e328133f29c","article-title":"Increased carotid intima media thickness and cardiac biomarkers in HIV infected children","volume":"21","author":"McComsey","year":"2007","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.ecl.2014.06.001_bib65","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3851\/IMP1437","article-title":"Increased arterial stiffness in HIV-infected children: risk factors and antiretroviral therapy","volume":"14","author":"Charakida","year":"2009","journal-title":"Antivir Ther"},{"issue":"5","key":"10.1016\/j.ecl.2014.06.001_bib66","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/tropej\/fmq089","article-title":"Dyslipidemia in a cohort of HIV-infected Latin American children receiving highly active antiretroviral therapy","volume":"57","author":"Brewinski","year":"2011","journal-title":"J\u00a0Trop Pediatr"},{"issue":"5","key":"10.1016\/j.ecl.2014.06.001_bib67","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1468-1293.2008.00682.x","article-title":"Correction of facial lipoatrophy using autologous fat transplants in HIV-infected adolescents","volume":"10","author":"Dollfus","year":"2009","journal-title":"HIV Med"},{"issue":"2","key":"10.1016\/j.ecl.2014.06.001_bib68","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1017\/S0954422411000138","article-title":"Nutrition and the HIV-associated lipodystrophy syndrome","volume":"25","author":"Loonam","year":"2012","journal-title":"Nutr Res Rev"},{"issue":"3","key":"10.1016\/j.ecl.2014.06.001_bib69","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/QAI.0b013e31824330cb","article-title":"Body fat abnormality in HIV-infected children and adolescents living in Europe: prevalence and risk factors","volume":"59","author":"Alam","year":"2012","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"5\u20136","key":"10.1016\/j.ecl.2014.06.001_bib70","first-page":"529","article-title":"Metabolic disorders in vertically HIV-infected children: future adults at risk for cardiovascular disease","volume":"25","author":"Dapena","year":"2012","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2014.06.001_bib71","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/INF.0b013e3182755a34","article-title":"Prevalence of lipodystrophy in HIV-infected children in Tanzania on highly active antiretroviral therapy","volume":"32","author":"Kinabo","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.ecl.2014.06.001_bib72","doi-asserted-by":"crossref","first-page":"17427","DOI":"10.7448\/IAS.15.2.17427","article-title":"Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study","volume":"15","author":"Piloya","year":"2012","journal-title":"J\u00a0Int AIDS Soc"},{"issue":"8","key":"10.1016\/j.ecl.2014.06.001_bib73","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1177\/135965350701200811","article-title":"Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy","volume":"12","author":"Aurpibul","year":"2007","journal-title":"Antivir Ther"},{"issue":"4","key":"10.1016\/j.ecl.2014.06.001_bib74","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jac\/dkn251","article-title":"HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options","volume":"62","author":"Mallewa","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.ecl.2014.06.001_bib75","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/01.aids.0000131334.38172.01","article-title":"Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe","volume":"18","author":"European Paediatric Lipodystrophy Group","year":"2004","journal-title":"AIDS"},{"issue":"13","key":"10.1016\/j.ecl.2014.06.001_bib76","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1097\/00002030-200409030-00004","article-title":"Metabolic complications of HIV therapy in children","volume":"18","author":"McComsey","year":"2004","journal-title":"AIDS"},{"issue":"16","key":"10.1016\/j.ecl.2014.06.001_bib77","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1097\/00002030-199911120-00019","article-title":"Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy","volume":"13","author":"Kakuda","year":"1999","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.ecl.2014.06.001_bib78","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S1473-3099(07)70287-6","article-title":"HIV-associated dyslipidaemia: pathogenesis and treatment","volume":"7","author":"Oh","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ecl.2014.06.001_bib79","doi-asserted-by":"crossref","first-page":"18600","DOI":"10.7448\/IAS.16.1.18600","article-title":"Metabolic complications and treatment of perinatally HIV-infected children and adolescents","volume":"16","author":"Barlow-Mosha","year":"2013","journal-title":"J\u00a0Int AIDS Soc"},{"issue":"18","key":"10.1016\/j.ecl.2014.06.001_bib80","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1097\/00002030-199912240-00002","article-title":"Fat distribution and metabolic changes in patients with HIV infection","volume":"13","author":"Safrin","year":"1999","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.ecl.2014.06.001_bib81","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00126334-200308150-00004","article-title":"An objective lipodystrophy severity grading scale derived from the lipodystrophy case definition score","volume":"33","author":"Carr","year":"2003","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.ecl.2014.06.001_bib82","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/135965350701200303","article-title":"Normalization of fat accrual in lipoatrophic, HIV-infected children switched from stavudine to tenofovir and from protease inhibitor to efavirenz","volume":"12","author":"Vigano","year":"2007","journal-title":"Antivir Ther"},{"issue":"8","key":"10.1016\/j.ecl.2014.06.001_bib83","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00431-013-2018-3","article-title":"Long-term body composition and metabolic changes in HIV-infected children switched from stavudine to tenofovir and from protease inhibitors to efavirenz","volume":"172","author":"Fabiano","year":"2013","journal-title":"Eur J Pediatr"},{"issue":"3","key":"10.1016\/j.ecl.2014.06.001_bib84","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1517\/14740330903579991","article-title":"Metabolic complications associated with antiretroviral therapy in HIV-infected and HIV-exposed uninfected paediatric patients","volume":"9","author":"Vigano","year":"2010","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"10.1016\/j.ecl.2014.06.001_bib85","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1210\/jc.2004-2431","article-title":"Effects of recombinant growth hormone on visceral fat accumulation: pilot study in human immunodeficiency virus-infected adolescents","volume":"90","author":"Vigano","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2014.06.001_bib86","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.qai.0000139397.30612.96","article-title":"Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219C","volume":"38","author":"Farley","year":"2005","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.ecl.2014.06.001_bib87","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1542\/peds.2007-2467","article-title":"Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy","volume":"122","author":"Chantry","year":"2008","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ecl.2014.06.001_bib88","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/QAI.0b013e318243760b","article-title":"Lipid profiles in young HIV-infected children initiating and changing antiretroviral therapy","volume":"60","author":"Strehlau","year":"2012","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"12","key":"10.1016\/j.ecl.2014.06.001_bib89","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/INF.0b013e3181ed9f4c","article-title":"Associations of proinflammatory cytokine levels with lipid profiles, growth, and body composition in HIV-infected children initiating or changing antiretroviral therapy","volume":"29","author":"Cervia","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.ecl.2014.06.001_bib90","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/QAI.0b013e3181648e16","article-title":"Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children","volume":"47","author":"Tassiopoulos","year":"2008","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.ecl.2014.06.001_bib91","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/01.qai.0000138420.38995.86","article-title":"Tolerability and safety of HIV protease inhibitors in adults","volume":"37","author":"Sax","year":"2004","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.ecl.2014.06.001_bib92","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1086\/381783","article-title":"Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?","volume":"189","author":"Fontas","year":"2004","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.ecl.2014.06.001_bib93","first-page":"174","article-title":"Switching to atazanavir improves metabolic disorders in antiretroviral-experienced patients with severe hyperlipidemia","volume":"39","author":"Mobius","year":"2005","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.ecl.2014.06.001_bib94","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/archdischild-2012-302633","article-title":"Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy","volume":"98","author":"Arpadi","year":"2013","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ecl.2014.06.001_bib95","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-2334-8-144","article-title":"Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children","volume":"8","author":"Gonzalez-Tome","year":"2008","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.ecl.2014.06.001_bib96","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1542\/peds.111.3.e275","article-title":"Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study","volume":"111","author":"McComsey","year":"2003","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.ecl.2014.06.001_bib97","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1177\/135965350501000807","article-title":"Improvement in dyslipidaemia after switching stavudine to tenofovir and replacing protease inhibitors with efavirenz in HIV-infected children","volume":"10","author":"Vigano","year":"2005","journal-title":"Antivir Ther"},{"issue":"Suppl 5","key":"10.1016\/j.ecl.2014.06.001_bib98","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1542\/peds.2009-2107C","article-title":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report","volume":"128","author":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ecl.2014.06.001_bib99","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1517\/17425255.4.1.37","article-title":"Metabolic complications of antiretroviral therapy in HIV-infected children","volume":"4","author":"Eley","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"6","key":"10.1016\/j.ecl.2014.06.001_bib100","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1159\/000332957","article-title":"Factors associated with insulin resistance among children and adolescents perinatally infected with HIV-1 in the pediatric HIV\/AIDS cohort study","volume":"76","author":"Geffner","year":"2011","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"10.1016\/j.ecl.2014.06.001_bib101","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1530\/EJE-07-0414","article-title":"Evaluation of insulin resistance in a cohort of HIV-infected youth","volume":"157","author":"Rosso","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2014.06.001_bib102","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2174\/157016211797635946","article-title":"Lipodystrophy, insulin resistance, and adiponectin concentration in HIV-infected children and adolescents","volume":"9","author":"Vigano","year":"2011","journal-title":"Curr HIV Res"},{"issue":"1","key":"10.1016\/j.ecl.2014.06.001_bib103","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1210\/jc.2004-0125","article-title":"Insulin sensitivity and beta-cell function in protease inhibitor-treated and -naive human immunodeficiency virus-infected children","volume":"90","author":"Bitnun","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2014.06.001_bib104","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/0044011-200929020-00004","article-title":"Long-term evaluation of glucose homeostasis in a cohort of HAART-treated HIV-infected children: a longitudinal, observational cohort study","volume":"29","author":"Vigano","year":"2009","journal-title":"Clin Drug Investig"},{"issue":"1","key":"10.1016\/j.ecl.2014.06.001_bib105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-3955(03)00113-5","article-title":"Current concepts in pediatric bone disease","volume":"49","author":"Leonard","year":"2002","journal-title":"Pediatr Clin North Am"},{"issue":"11","key":"10.1016\/j.ecl.2014.06.001_bib106","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1359\/jbmr.2000.15.11.2245","article-title":"Calcium accretion in girls and boys during puberty: a longitudinal analysis","volume":"15","author":"Bailey","year":"2000","journal-title":"J\u00a0Bone Miner Res"},{"issue":"11","key":"10.1016\/j.ecl.2014.06.001_bib107","first-page":"3951","article-title":"Clinical review 117: hormonal determinants and disorders of peak bone mass in children","volume":"85","author":"Soyka","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"17","key":"10.1016\/j.ecl.2014.06.001_bib108","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review","volume":"20","author":"Brown","year":"2006","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.ecl.2014.06.001_bib109","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jbspin.2009.10.003","article-title":"Bone loss in patients with HIV infection","volume":"76","author":"Paccou","year":"2009","journal-title":"Joint Bone Spine"},{"issue":"9","key":"10.1016\/j.ecl.2014.06.001_bib110","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/jmv.21266","article-title":"HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFalpha activation","volume":"80","author":"Gibellini","year":"2008","journal-title":"J\u00a0Med Virol"},{"issue":"31","key":"10.1016\/j.ecl.2014.06.001_bib111","doi-asserted-by":"crossref","first-page":"13848","DOI":"10.1073\/pnas.1003020107","article-title":"Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats","volume":"107","author":"Vikulina","year":"2010","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"11","key":"10.1016\/j.ecl.2014.06.001_bib112","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/INF.0b013e318286c793","article-title":"The relationship between vitamin D status and HIV-related complications in HIV-infected children and young adults","volume":"32","author":"Eckard","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.ecl.2014.06.001_bib113","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1210\/jc.2003-031942","article-title":"Metabolic bone disease in human immunodeficiency virus-infected children","volume":"89","author":"Arpadi","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2014.06.001_bib114","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/QAD.0b013e328336095d","article-title":"Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045","volume":"24","author":"Jacobson","year":"2010","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.ecl.2014.06.001_bib115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/QAD.0b013e32835a9b80","article-title":"Bone mineral density in children and adolescents with perinatal HIV infection","volume":"27","author":"DiMeglio","year":"2013","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.ecl.2014.06.001_bib116","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/QAI.0000000000000112","article-title":"HIV infection and its association with an excess risk of clinical fractures: a nationwide case-control study","volume":"66","author":"Prieto-Alhambra","year":"2014","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"8","key":"10.1016\/j.ecl.2014.06.001_bib117","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1177\/135965350801300803","article-title":"Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study","volume":"13","author":"Fux","year":"2008","journal-title":"Antivir Ther"},{"issue":"3","key":"10.1016\/j.ecl.2014.06.001_bib118","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/cid\/ciq158","article-title":"Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population","volume":"52","author":"Dao","year":"2011","journal-title":"Clin Infect Dis"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852914000516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852914000516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:39:45Z","timestamp":1760175585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852914000516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":118,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0889852914000516"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2014.06.001","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrinopathies in Children Infected with Human Immunodeficiency Virus","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2014.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}